S&P 500
(0.03%) 5 088.80 points
Dow J
(0.16%) 39 132 points
Nasdaq
(-0.28%) 15 997 points
Oil
(-2.60%) $76.57
Gas
(-8.66%) $1.582
Gold
(0.74%) $2 045.80
Silver
(0.84%) $22.98
Platinum
(0.11%) $906.50
USD/EUR
(0.04%) $0.924
USD/NOK
(0.33%) $10.53
USD/GBP
(-0.12%) $0.789
USD/RUB
(0.62%) $93.60

Realtime updates for Cognition Therapeutics, [CGTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated23 Feb 2024 @ 15:57

-0.50% $ 2.00

Live Chart Being Loaded With Signals

Commentary (23 Feb 2024 @ 15:57):

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina...

Stats
Today's Volume 113 347
Average Volume 223 101
Market Cap 64.24M
EPS $-0.220 ( 2023-11-02 )
Next earnings date ( $-0.380 ) 2024-03-28
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.53
ATR14 $0.0130 (0.65%)
Insider Trading
Date Person Action Amount type
2024-02-15 Doyle John Brendan Buy 20 000 Common Stock
2024-02-15 Doyle John Brendan Buy 20 000 Stock Option (Right to Buy)
2024-02-15 Caggiano Anthony Buy 60 000 Common Stock
2024-02-15 Caggiano Anthony Buy 60 000 Stock Option (Right to Buy)
2024-02-15 Ricciardi Lisa Buy 75 000 Common Stock
INSIDER POWER
97.28
Last 94 transactions
Buy: 12 747 143 | Sell: 1 480 989

Volume Correlation

Long: -0.10 (neutral)
Short: 0.45 (neutral)
Signal:(60.021) Neutral

Cognition Therapeutics, Correlation

10 Most Positive Correlations
BOWXU0.909
AYLA0.897
AGCUU0.896
ASPS0.896
IRBT0.894
ARQQ0.878
AMD0.876
CELU0.875
OP0.873
SNPS0.872
10 Most Negative Correlations
IVAC-0.894
ULTA-0.889
ISEM-0.884
PAHC-0.882
CTLP-0.879
RCM-0.877
WFRD-0.876
STAY-0.872
IQ-0.872
IDLB-0.865

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cognition Therapeutics, Correlation - Currency/Commodity

The country flag -0.43
( neutral )
The country flag 0.40
( neutral )
The country flag 0.00
( neutral )
The country flag -0.45
( neutral )
The country flag -0.45
( neutral )
The country flag 0.78
( moderate )

Cognition Therapeutics, Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0.0320
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.220
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.160
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.120

Cognition Therapeutics,

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators